13th European Biosimilars Congress 2020
With 10 years now added to its repertoire, European Biosimilars Congress is really turning into a staple meeting where Biosimilars partners accumulate to address the present and future condition of Biosimilars in the Europe.
The expansion of two devoted streams for the European Biosimilars Congress meeting was a hit – we could pick up knowledge from two particular groups – one that exceeded expectations in the systematic and assembling end – and one that exceeded expectations in the business and key end.
The 2020 establishment of this meeting will enable us to keep on diving further into both the investigation of Biosimilars improvement – and the business requirements for organizations that keep on seeking FDA endorsement.
The Organizing Committee is delighted to invite you to attend the 13th European Biosimilars Congress one of its remarkable Pharmaceutical conferences, to be held during April 01-02, 2020 London, UK. European Biosimilars Congress is a global annual event. This European Biosimilars Congress 2020 will bring together scientists, researchers, business development managers, CEOs, directors, IP Attorneys, Regulatory Officials and CROs from around the world. Many biologics products are making their entry in the pharma market and experiencing a notable rise in their usage over the conventional medications.
At Euro Biosimilars 2020 meet your target audiences from around the world focused on learning about biologics and Biosimilars. This conference would be your single best opportunity to reach the largest assemblage of participants from the biologics and Biosimilars community.